DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Urinalysis and urine microscopy

Essential points for quick revision.

!
Escalate

Haematuria with rapidly falling renal function, proteinuria, hypertension, red-cell casts or pulmonary haemorrhage suggests rapidly progressive glomerulonephritis and needs urgent nephrology contact. Pyuria with sepsis and obstruction requires urgent drainage assessment; a urine result must not delay resuscitation.

Synopsis

Use dipstick, quantitative protein testing, culture and urine sediment together to localise renal and urinary disease while recognising contamination, false results and time-critical nephritic patterns.

  • A fresh midstream clean-catch sample with documented timing and symptoms is the starting point. Catheter, menstruation, vigorous exercise, antiseptic contamination and delayed analysis can change results.
  • Dipstick 'blood' detects haem pigment, not intact red cells. Haematuria, haemoglobinuria and myoglobinuria can all be positive; microscopy and the clinical setting separate them.
  • Nitrite supports nitrate-reducing bacteria but is insensitive with frequent voiding, low dietary nitrate or organisms that do not reduce nitrate. A negative result never excludes UTI or pyelonephritis.

Key red flags

Glomerular sediment

Protein with dysmorphic erythrocytes or red-cell casts, hypertension, oedema and impaired function favours glomerular inflammation. Systemic rash, haemoptysis or rapidly rising creatinine increases urgency.

Investigation priorities

01
Fresh reagent-strip urinalysisFirst step

Screen blood, leucocytes, nitrite, protein, glucose, ketones, pH and concentration at the bedside or laboratory.

Management branches

Active nephritic urineEscalate possible glomerulonephritis

Blood and protein with impaired function, hypertension, casts or systemic inflammatory features.

  1. Repeat a clean sample, quantify ACR/PCR, obtain urgent renal biochemistry, FBC and blood pressure, and review baseline and urine output.
  2. Discuss promptly with nephrology; send targeted complements, ANCA, ANA, anti-GBM, infection and paraprotein testing as advised rather than delaying referral for a complete panel.

Key medicines

Empirical antimicrobial for urinary infectionSelect agent, dose and duration from current local and NICE guidance using site, severity, culture history, allergy, pregnancy and renal function.
SGLT2 inhibitor awarenessContinue or pause only according to an individualised clinical sick-day and peri-procedure plan; timing varies by medicine, illness severity and procedure.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom